Skip to main content
SpringerLink
Log in

Trizyklische Antidepressiva

  • Chapter
Neuro-Psychopharmaka

Zusammenfassung

Trizyklische Antidepressiva lassen sich nach strukturchemischen und pharmakologischneurobiochemischen Gesichtspunkten sowie aufgrund ihrer psychotropen Wirkprofile einteilen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abernethy DR, Todd EL (1986) Doxepin-cimetidine interaction: increased doxepin bio-availability during cimetidine treatment. J Clin Psychopharmacol 6: 8–12

    PubMed  CAS  Google Scholar 

  • Abernethy DR, Greenblatc DJ, Shader RI (1985) Imipramine and desipramine disposition in the elderly. J Pharmacol Exp Ther 232: 183–188

    PubMed  CAS  Google Scholar 

  • Balant-Gorgia AE, Balant LP, Garrone G (1989) High blood concentrations of imipramine or clomipramine and therapeutic failure: a case report study using drug monitoring data. Ther Drug Monit 11: 415–420

    PubMed  CAS  Google Scholar 

  • Bickel MH (1980) Metabolism of antidepressants. In: Hoffmeister F, Stille G (eds) Psychotropic agents. Springer, Berlin Heidelberg New York, pp 551–572 (Handbook of experimental pharmacology, vol 55/I)

    Google Scholar 

  • Boyer WF, Lake CR (1987) Initial severity and diagnosis influence the relationship of tricyclic plasma levels to response: a statistical review. J Clin Psychopharmacol 7: 67–71

    PubMed  CAS  Google Scholar 

  • Breyer-Pfaff U (1980) Bestimmung der Plasmaspiegel von Psychopharmaka: ein Beitrag zur Optimierung der Therapie? In: KRYSPINEXNER K et al. (Hrsg) Therapie akuter psychiatrischer Syndrome. Schattauer, Stuttgart New York, S 39–50

    Google Scholar 

  • Breyer-Pfaff U, Gaertner HJ (1987) Antidepressiva. Pharmakologie, therapeutischer Einsatz und Klinik der Depression. Schattauer, Stuttgart, S 148–150

    Google Scholar 

  • Breyer-Pfaff U, Brinkschulte M (1989) Binding of tricyclic psychoactive drugs in plasma: contribution of individual proteins and drug interactions. In: Baumann P et al. (eds) Alphas-acid glycoprotein: genetics, biochemistry, physiological functions, and pharmacology. Alan R Liss, New York, pp 351–361

    Google Scholar 

  • Breyer-Pfaff U, Giedke H, Gaertner HJ, Nill K (1989) Validation of a therapeutic plasma level range in amitriptyline treatment of depression. J Clin Psychopharmacol 9: 116–121

    PubMed  CAS  Google Scholar 

  • Brinksci-Iulte M, Breyer-Pfaff U (1979) Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals. Naunyn Schmiedebergs Arch Pharmacol 308: 1–7

    Google Scholar 

  • Brosen K, Gram LF (1989) Clinical significance of the sparteine/debrisoquine oxidation polymorphism. Eur J Clin Pharmacol 36: 537–547

    PubMed  CAS  Google Scholar 

  • Brçsen K, Gram LF, Klysner R, Bech P (1986) Steady-state levels of imipramine and its metabolites: significance of dose dependent kinetics. Eur J Clin Pharmacol 30: 43–49

    Google Scholar 

  • Burgh JE, Hullin RP (1981) Amitriptyline pharmacokinetics. Single doses of lentizol compared with ordinary amitriptyline tablets. Psycho-pharmacology 74: 43–50

    Google Scholar 

  • Burch JE, Roberts SG, Raddats MA (1981) Binding of amitriptyline and nortriptyline in plasma determined from their equilibrium distribution between red cells and plasma, and between red cells and buffer solution. Psycho-pharmacology 75: 262–272

    CAS  Google Scholar 

  • Crome P, Dawling S, Braithwaite RA, Masters J, Walkey R (1977) Effect of activated charcoal on absorption of nortriptyline. Lancet ii: 1203–1205

    Google Scholar 

  • Dawling S (1988) Is there a practical alternative to therapeutic drug monitoring in therapy with tricyclic antidepressants? Clin Chem 34: 841–847

    PubMed  CAS  Google Scholar 

  • Dawling S, Lynn K, Rosser R, Braithwaite R (1982) Nortriptyline metabolism in chronic renal failure: metabolite elimination. Clin Pharmacol Ther 32: 322–329

    PubMed  CAS  Google Scholar 

  • Faravelli C, Ballerini A, Ambonetti A, Broadhurst AD, Das M (1984) Plasma levels and clinical response during treatment with clomipramine. J Affective Disord 6: 95–107

    CAS  Google Scholar 

  • Faulkner RD, Pitsw M, Lee CS, Lewis WA, Fann WE (1983) Multiple-dose doxepin kinetics in depressed patients. Clin Pharmacol Ther 34: 509–515

    PubMed  CAS  Google Scholar 

  • Filser JG, Kaumeier S, Brand T, Schanz H, Terlinden R, Müller WE (1988) Pharmacokinetics of amitriptyline and amitriptylinoxide after intravenous or oral administration in humans. Pharmacopsychiatry 21: 381–383

    PubMed  CAS  Google Scholar 

  • Gauch R, Modestin J (1973) Zur Pharmakokinetik von Dibenzepin. Arzneimittelforschung 23: 687–690

    PubMed  CAS  Google Scholar 

  • Geller B, Cooper TB, Chestnut E, Abel AS, Anker JA (1984) Nortriptyline pharmacokinetic parameters in depressed children and adolescents: preliminary data. J Clin Psychopharmacol 4: 265–269

    PubMed  CAS  Google Scholar 

  • Glassman AH, Perel JM, Shostak M, Kantor SJ, Fleiss JL (1977) Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry 34: 197–204

    PubMed  CAS  Google Scholar 

  • Gram LF (1977) Plasma level monitoring of tricyclic antidepressant therapy. Clin Pharmacokinet 2: 237–251

    PubMed  CAS  Google Scholar 

  • Gram LF (1980) Pharmacokinetics and clinical response to tricyclic antidepressants. Acta Psychiatr Scand 61 [Suppl 2801: 169–177

    Google Scholar 

  • Kragh-Sorensen P (1980) The use of clinical kinetic data in treatment with antidepressant drugs. Acta Psychiatr Scand 61 [Suppl 280]: 157–167

    Google Scholar 

  • Kragh-Sorensen P, Larsen NE (1980) Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels. Clin Pharmacol Ther 28: 796–803

    PubMed  CAS  Google Scholar 

  • Kristensen CB (1983) Imipramine serum protein binding in healthy subjects. Clin Pharmacol Ther 34: 689–694

    PubMed  CAS  Google Scholar 

  • Kuss HJ, Jungkunz G, Johannes KJ (1985) Single oral dose pharmacokinetics of amitriptylineoxide and amitriptyline in humans. Pharmacopsychiatry 18: 259–262

    PubMed  CAS  Google Scholar 

  • Lancaster SG, Gonzalez JP (1989a) Lofepramine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 37: 123–140

    Google Scholar 

  • Lancaster SG, Gonzalez JP (1989b) Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 38: 123–147

    Google Scholar 

  • Linnoii.A M, George L, Guthrie S, Leventhal B (1981) Effect of alcohol consumption and cigarette smoking on antidepressant levels of depressed patients. Am J Psychiatry 138: 84 1842

    Google Scholar 

  • Linnoii.A M, George L, Guthrie S (1982) Interaction between antidepressants and perphenazine in psychiatric patients. Am J Psychiatry 139: 1329–1331

    Google Scholar 

  • Maguire KP, Burrows GD, Norman TR, Scoggins BA (1980) Blood/plasma distribution ratios of psychotropic drugs. Clin Chem 26: 1624–1625

    PubMed  CAS  Google Scholar 

  • Martensson E, Axelsson R, Nyberg G, Svensson C (1984) Pharmacokinetic properties of the antidepressant drugs amitriptyline, clomipramine, and imipramine: a clinical study. Curr Ther Res 36: 228–238

    Google Scholar 

  • Midgley I, Hawkins DR, Chasseaud LF (1978) The metabolic fate of the antidepressive agent amitriptylinoxide in man. Arzneimittelforschung 28: 1911–1916

    PubMed  CAS  Google Scholar 

  • Nagy A, Johansson R (1977) The demethylation of imipramine and clomipramine as apparent from their plasma kinetics. Psychopharmacology 54: 125–131

    PubMed  CAS  Google Scholar 

  • Nelson JC, Mazure C, Jatlow PI (1988) Antidepressant activity of 2-hydroxydesipramine. Clin Pharmacol Ther 44: 283–288

    PubMed  CAS  Google Scholar 

  • Nordin C, Bertilsson L, Siwers B (1985) CSF and plasma levels of nortriptyline and its 10-hydroxy metabolite. Br J Clin Pharmacol 20: 411413

    Google Scholar 

  • Perry PJ, Pfohl BM, Holstad SG (1987) The relationship between antidepressant response and tricyclic antidepressant plasma concentrations: a retrospective analysis of the literature using logistic regression analysis. Clin Pharmacokinet 13: 381–392

    PubMed  CAS  Google Scholar 

  • Petit JM, Spiker DG, Ruwitch JF, Ziegler VE, Weiss AN, Biggs JT (1977) Tricyclic antidepressant plasma levels and adverse effects after overdose. Clin Pharmacol Ther 21: 47–51

    PubMed  CAS  Google Scholar 

  • Potter WZ, Calil HM, Sutfin TA, Zavadil AP III, Jusko WJ, Rapoport J, Goodwin FK (1982) Active metabolites of imipramine and desipramine in man. Clin Pharmacol Ther 31: 393–401

    PubMed  CAS  Google Scholar 

  • Preskorn SH, Jerkovich GS (1990) Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring. J Clin Psychopharmacol 10: 88–95

    PubMed  CAS  Google Scholar 

  • Rollins DE, Alvan G, Bertilsson L, gillecie JR, Mellström B, Sjöqvist F, Träskman L (1980) Interindividual differences in amitriptyline demethylation. Clin Pharmacol Ther 28: 12 1129

    Google Scholar 

  • Schulz P, Dick P, Blaschke TF, Hollister L (1985) Discrepancies between pharmacokinetic studies of amitriptyline. Clin Pharmacokinet 10: 257–268

    PubMed  CAS  Google Scholar 

  • Stancer HC, Reed KL (1986) Desipramine and 2hydroxydesipramine in human breast milk and the nursing infant’s serum. Am J Psychiatry 143: 1597–1600

    PubMed  CAS  Google Scholar 

  • Vandel B, Sandoz M, Vandel S, Allers G, Volmat R (1982) Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites. Eur J Clin Pharmacol 22: 239–245

    PubMed  CAS  Google Scholar 

  • Young RC, Alexopoulos GS, Shamoian CA, Man-Ley MW, Dhar AK, Kurr H (1984) Plasma 10hydroxynortriptyline in elderly depressed patients. Clin Pharmacol Ther 35: 540–544

    PubMed  CAS  Google Scholar 

  • Breyer-Pfaff U, Gaertner HJ (1987) Antidepressiva, Pharmakologie, therapeutischer Einsatz und Klinik der Depression. In: AMMON HPT, WERNING C (Hrsg) Medizinisch-pharmakologisches Kompendium, Bd 5. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart

    Google Scholar 

  • Delini-Stula A (1987) Biochemische Klassifizierung der Antidepressiva und deren klinische Validierung. In: Simhandl C, Berner P, Loccioni H, Alf C (Hrsg) Psychiatrie. Klassifikationsprobleme in der Psychiatrie. MVP, Purkersdorf, S 131–148

    Google Scholar 

  • Delini-Stuta A (1989) Animal models in the research of antidepressants and their experimental validation. Habilitation, Universität Basel

    Google Scholar 

  • Delini-Stula A, Vassout A (1981) The effects of antidepressants on aggressiveness induced by social deprivation in mice. Pharmacol Biochem Behav 14 [Suppl 1]: 33–41

    PubMed  CAS  Google Scholar 

  • Kielholz P (1971) Diagnose und Therapie der Depression für den Praktiker. Lehmann, München

    Google Scholar 

  • Langer G, Schönbeck G (1983) Psychiatrische Indikationen der Therapie mit Antidepressiva. In: Langer G, Heimann H (Hrsg) Psychopharmaka. Grundlagen und Therapie. Springer, Wien New York, S 118–136

    Google Scholar 

  • Lapin LP, Oxenkrug GF (1969) Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet i: 132–136

    Google Scholar 

  • Maître L, Moser P, Baumann PA, Waldmeier PC (1980) Amine uptake inhibitors: criteria of selectivity. Biogenic amines and affective disorders. Acta Psychiatr Scand 61 [Suppl 2801: 97–110

    Google Scholar 

  • Maître L, Baumann PA, Jaekel J, Waldmeier PC (1982) 5-HT-uptake inhibitors: psychopharmacological and neurobiological criteria of selectivity. Adv Biochem Psychopharmacol 34: 229–246

    Google Scholar 

  • Mai J, Przegalinski E, Mogilnicka E (1984) Hypothesis concerning the mechanism of action of antidepressant drugs. Rev Physiol Biochem Pharmacol 100: 1–74

    Google Scholar 

  • Randrup A, Braestrup C (1977) Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology 53: 309–314

    PubMed  CAS  Google Scholar 

  • Richelson E (1989) Antidepressants: pharmacology and clinical use. In: KARASU TB (ed) Treatments of psychiatric disorders: a task force report of the American Psychiatric Association, vol 3, 1st ed. Am Psych Press, Washington DC, pp 1775–1787

    Google Scholar 

  • Richelson E (1991) Biological basis of depression and therapeutic relevance. J Clin Psychiatry 52 [Suppl 61: 4–10

    Google Scholar 

  • Richelson E, Pfennig M (1984) Blockade by antidepressants and related compounds of bio-genic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 104: 227–286

    Google Scholar 

  • Richelson E, Nelson A (1984) Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 230: 94–102

    PubMed  CAS  Google Scholar 

  • Roos SP, Glassman AH (1990) Cardiovascular effects of tricyclic antidepressants in depressed patients with and without heart disease. In: Dekker M (ed) Pharmacotherapy of depression. Applications for the outpatient practioner. Elsevier, Amsterdam New York Basel, pp 267–280

    Google Scholar 

  • Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 509–522

    PubMed  CAS  Google Scholar 

  • Spiegel R (1988) Einführung in die Psychopharmakologie. Huber, Bern, S 271

    Google Scholar 

  • Sulser F (1978) Functional aspects of the nor-epinephrine receptor coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate of alleviate depression: molecular approaches to an understanding of affective disorder. Pharmacopsychiatry 11: 42–43

    Google Scholar 

  • Thompson PJ, Trimble MR (1982) Non-MAOI antidepressant drugs and cognitive functions: a review. Psychol Med 12: 539–548

    PubMed  CAS  Google Scholar 

  • Vetulani J, Sulser F (1975) Actions of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating sy- stem in limbic forebrain. Nature 257: 495–496

    PubMed  CAS  Google Scholar 

  • Wachtel H (1988) Defective second-messenger function in the etiology of endogenous depression. Novel therapeutic approaches. In: Briley M, FiLiou G (eds) New concepts in depression. MacMillan, London, pp 277–293

    Google Scholar 

  • Waldmeier PC (1983) Neurobiochemische Wirkungen antidepressiver Substanzen. In: Langer G, Heinemann H (Hrsg) Psychopharmaka. Grundlagen und Therapie. Springer, Wien New York, S 65–81

    Google Scholar 

  • Willner P (1985) Depression. A psychobiological synthesis. Wiley, New York

    Google Scholar 

  • Willner P (1989) Sensitisation of the action of antidepressant drugs. In: GONDIL AJ, EMMETrOGLESBY M (eds) Psychoactive drugs. Humana Press, Clifton NJ, pp 407–459

    Google Scholar 

  • Alexander GE, Delong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 9: 357–381

    PubMed  CAS  Google Scholar 

  • Arango V, Ernsberger P, Marzuk PM et al. (1990) Autoradiographic demonstration of increased serotonin 5-HT2 and 13-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47: 1038–1047

    PubMed  CAS  Google Scholar 

  • Avissar S, Schreiber G (1989) Muscarinic receptor subclassification and G-proteins: significance for lithium action in affective disorders and for the treatment of the extrapyramidal side effects of neuroleptics. Biol Psychiatry 26: 113–130

    PubMed  CAS  Google Scholar 

  • Bakker M, Mckernan RM, Wong EHF, Foster AC (1991) [3H]MK-801 binding to N-methyl-daspartate receptors solubilized from rat brain: effects of glycine site ligands, polyamines, ifenprodil, and desipramine. J Neurochem 57: 39–45

    Google Scholar 

  • Biegon A, Israeli M (1988) Regionally selective increase in (3-adrenergic receptor density in the brains of suicide victims. Brain Res 442: 199–203

    PubMed  CAS  Google Scholar 

  • Birkmayer W, Riederer P (1975) Biochemical post-mortem findings in depressed patients. J Neural Transm 37: 95–109

    PubMed  CAS  Google Scholar 

  • Birkmayer W, Riederer P (1988) Depression, 4. Aufl. Deutscher Ärzte-Verlag, Köln

    Google Scholar 

  • Blakely RD, Berson HE, fremeau RT, Caron MC, Peek MM, Prince HK, Bradley CC (1991) Cloning and expression of functional serotonin transporter from rat brain. Nature 354: 66–70

    PubMed  CAS  Google Scholar 

  • Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 15: 6–31

    PubMed  CAS  Google Scholar 

  • Brücke T, Sofic E, Riederer P, Gabriel E, Jellinger K, Danielczyk W (1984) Die Bedeutung der serotonergen Raphe-Kortex-Projektion für die Beeinflussung der ß-adrenergen Neurotransmission durch Antidepressiva. Neuropsychiatr Clin 3: 249–255

    Google Scholar 

  • Bunney WE, Bunney BG (1990) A view of psycho-pharmacology, neuro-science, and the major psychoses. In: Bunney WE, Hippius H, Laakmann G, Schmauss G (eds) Neuropsychopharmacology 1. Springer, Berlin Heidelberg New York Tokyo, pp 11–26

    Google Scholar 

  • Cheetham SC, Crompton MR, Katona CLE, Norton RW (1988) Brain 5-HT2 receptor binding sites in depressed suicide victims. Brain Res 443: 272–280

    PubMed  CAS  Google Scholar 

  • Coppen A (1967) The biochemistry of affective disorders. Br J Psychiatry 113: 1235–1264 Cortes

    Google Scholar 

  • R, Soriano E, Pazos A, Probst A, Palacios JM (1988) Autoradiography of antidepressant binding sites in the human brain: localization using [3H] imipramine and [3H1 paroxetine. Neuroscience 27: 473–496

    Google Scholar 

  • Crane GE (1957) Iproniazid (Marsilid) phosphate, a therapeutic agent for mental disorders and debilitating disease. Psychiatry Res Rep 8: 142–152

    CAS  Google Scholar 

  • Crow TJ, Cross AJ, Cooper SJ, Deakin JEW, Ferrier IN, Johnson JA, Joseph MH, Owen F, Paulter M, Lofthouse R, Corsellis JAN, Chambers DR, Blessed G, Perry EK, Perry RH, Tomlinson BE (1984) Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression and suicides. Neuropharmacology 23: 1561–1569

    PubMed  CAS  Google Scholar 

  • Delay J, Deniker P (1952) Le traitement des psychoses par une méthode neurolytique dérivee le l’hibernothérapie. In: Cossa P, Maison P (eds) Congres de Médicins alienistes et neurologists de France, vol 50. Libraire del’académie de Médicine, Paris, pp 497–502

    Google Scholar 

  • Paermentier F, Cheetham SC, Crompton MR et al. (1990) Brain a-adrenoceptor binding sites in antidepressant-free depressed suicide victims. Brain Res 525: 71–77

    PubMed  Google Scholar 

  • Dixon JF, Lee CH, Los GV, Hokin LE (1992) Lithium enhances accumulation of [3H]inositol radioactivity and mass of second messenger inositol-1,4,5-triphosphate in monkey cerebral cortex slices. J Neurochem 59: 2332–2335

    PubMed  CAS  Google Scholar 

  • Dudley M, Baron M (1989) The 5-HT,,, site is involved in the rapid down-regulation of cortical j3-adrenoreceptors ((3-rec). 22nd Winter Conf Brain Res, January 21–28, 1989. Snowbird, Utah

    Google Scholar 

  • Emrich HM, Berger M, Riemann D et al. (1987) Serotonin reuptake inhibition vs. norepinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives. Pharmacopsychiatry 20: 60–63

    PubMed  CAS  Google Scholar 

  • Fritze J, Koronakis P, Riederer P (1989) Erythrozyten-Membran-proteine bei Schizophrenien und affektiven Psychosen. In: Saletu B (Hrsg) Biologische Psychiatrie. G Thieme, Stuttgart New York, S 246–247

    Google Scholar 

  • Fritze J, Deckert J, Lanczik M, Strik W, Struck M, Wodarz N (1992) Zum Stand der Aminhypothesen depressiver Erkrankungen. Nervenarzt 63: 3–13

    PubMed  CAS  Google Scholar 

  • Garratini S, Samanin R (1988) Biochemical hypotheses on antidepressant drugs: a guide for clinicians or a toy for pharmacologists? Psychol Med 18: 287–304

    Google Scholar 

  • Goodwin FK, Ebert MH, Bunney WE (1972) Mental effects of reserpine in man: a review. In: Shader EE (ed) Psychiatric complications of medical drugs. Raven Press, New York, pp 73–101

    Google Scholar 

  • Graham D, Langer SZ (1992) Advances in sodium-ion coupled biogenic amine transportes. Life Sci 51: 631–645

    PubMed  CAS  Google Scholar 

  • Heimer L, Wilson RD (1975) The subcortical projections of the allocortex. Similarities in the neural associations of the hippocampus, the piriform cortex and the neocortex. In: Santini M (ed) Golgi centenary symposium: perspectives in neurology. Raven Press, New York, pp 177–193

    Google Scholar 

  • Hoffman BJ, Mezey E, Brownstein M (1991) Cloning of a serotonin transporter affected by antidepressants. Science 254: 579–580

    PubMed  CAS  Google Scholar 

  • Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303–326

    PubMed  CAS  Google Scholar 

  • Janowsky DS, El-Yousef MK, Davis JM, Sekerke HJ (1972) A cholinergic-adrenergic hypothe- sis of mania and depression. Lancet ii: 632–635

    Google Scholar 

  • Jellinger K, Braak H, Braak E, Fischer P (1991) Alzheimer lesions in the entorhinal region and isocortex in Parkinson’s and Alzheimer’s diseases. Ann NY Acad Sci 640: 203–209

    PubMed  CAS  Google Scholar 

  • Kraepelin E (1892) Über die Beeinflussung einfacher psychischer Vorgänge durch einige Arzneimittel. Fischer, Jena

    Google Scholar 

  • Lancaster JM, Davies JA (1991) Desmethylimipramine potentiates NMDA responses in a mouse cortical slice preparation. Neuro Report 2: 665–668

    CAS  Google Scholar 

  • Leonard BE (1991) Antidepressants — current concepts of mode of action. L’Encéphale 17: 127–131

    CAS  Google Scholar 

  • Lesch KP, Rupprecht R (1989) Psychoneuroendocrine research in depression. II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction. J Neural Transm 75: 179–194

    Google Scholar 

  • Lesch KP, Aulakh CS, Tolliver TJ, Hill JL, Murphy DL (1991) Regulation of G proteins by chronic antidepressant drug treatment in rat brain: tricyclics but nor clorgyline increase Go a subunits. Eur J Pharmacol Mol Pharmacol Sect 207: 361–364

    CAS  Google Scholar 

  • Lesch KP, Hough CJ, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Akiyoshi J, Chuang DM, Murphy DL (1992) Fluoxetine modulates G protein a,, aq and aie subunit mRNA expression in rat brain. Eur J Pharmacol Mol Pharmacol Sect 227: 233–237

    CAS  Google Scholar 

  • Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P (1993) Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm 91: 67–73

    CAS  Google Scholar 

  • Tam YK, Young LT, Warsh JJ (1991) Lithium decreases Gi-1, Gi2 a-subunits mRNA levels in rat cortex. Eur J Pharmacol Mol Pharmacol Sect 206: 165–167

    Google Scholar 

  • Lloyd KG, Zivkovic B, Scatton B, Morselli PL, Bartholini G (1989) The GABAergic hypothesis of depression. Prog Neuropsychopharmacol Biol Psychiatry 13: 341–351

    PubMed  CAS  Google Scholar 

  • Maj J, Rogoz Z, Skuza G, Sowinska H (1992) Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacol 2: 37–41

    PubMed  CAS  Google Scholar 

  • Manji H, Brown JH (1987) The antidepressant effect of beta-adrenoreceptor subsensitivity: a brief review and clinical implications. Can J Psychiatry 32: 788–797

    PubMed  CAS  Google Scholar 

  • Mann JJ, Stanley M, Mcbride A, Mcewan BS (1986) Increased serotonin2 and a-adrenergic receptor binding in the frontal cortices of sui- cide victims. Arch Gen Psychiatry 43: 954–959

    PubMed  CAS  Google Scholar 

  • Maurer K, Riederer P, Heinsen H, Beckmann H (1989) Altered P300 topography due to functional and structural disturbances in the limbic system in dementia and psychoses and to pharmacological conditions. Psychiatry Res 29: 391–393

    PubMed  CAS  Google Scholar 

  • Mayser W, Betz H, Schloss P (1991) Isolation of cDNA encoding a novel member of the neurotransmitter transporter gene family. FEBS Lett 295: 203–206

    PubMed  CAS  Google Scholar 

  • Neumayer E, Riederer P, Danielczyk W, Seemann D (1975) Biochemische Hirnbefunde bei endogener Depression. Wien Med Wochenschr 21: 344–349

    Google Scholar 

  • Ozawa H, Rasenick MM (1989) Coupling Of the stimulatory GTP-binding protein G, to rat synaptic membrane adenylate cyclase is enhanced subsequent to chronic antidepressant treatment. Mol Pharmacol 36: 803–808

    PubMed  CAS  Google Scholar 

  • Ozawa H, Rasenick MM (1991) Chronic electroconvulsive treatment augments coupling of the GTP-binding protein G, to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. J Neurochem 56: 330–338

    PubMed  CAS  Google Scholar 

  • Ozawa H, Katamura Y, Hatta S, Saito T, Katada T, Gsell W, Frölich L, Takahata N, Riederer P (1993) Alterations of guanine nucleotide bindinc proteins in post-mortem human brain in alcoholism. Brain Res (in Druck)

    Google Scholar 

  • Perez J, Tinelli D, Brunello N, Racagni G (1989) cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur J Pharmacol Mol Pharmacol Sect 172: 305–316

    Google Scholar 

  • Perry EK, Marshall EF, Blessed G, Tomlinson BE, Perry RH (1983) Decreased imipramine binding in the brains of patients with depressive illness. Br J Psychiatry 142: 188–192

    PubMed  CAS  Google Scholar 

  • Praag HM, Korf J (1971) Retarded depression and the dopamine metabolism. Psychopharmacologia 19: 199

    PubMed  Google Scholar 

  • Racagni G, Brunello N (1984) Transsynaptic mechanisms in the action of antidepressant drugs. Trends Pharmacol Sci 5: 527

    CAS  Google Scholar 

  • Richardson JS (1991) Animal models of depression reflect changing views on the essence and etiology of depressive disorders in human. Prog Neuropsychopharmacol Biol Psychiatry 15: 199–204

    PubMed  CAS  Google Scholar 

  • Richelson E (1991) Biological basis of depression and therapeutic relevance. J Clin Psychiatry 52 [Suppl]: 4–10

    PubMed  Google Scholar 

  • Riederer P, Birkmayer W (1993a) Pathobiochemie bei Depressionen. 1. Alle Defizitmodelle sind heute überholt. Ärztl Prax 45 (14): 27–29

    Google Scholar 

  • Riederer P, Birkmayer W (1993b) Pathobiochemie bei Depressionen. 2. Ungleichgewicht zwischen den Überträgersystemen? Ärztl Prax 45 (15): 26–30

    Google Scholar 

  • Riederer P, Beckmann H, Brücke T (1985) Aktuelle biochemische Hypothesen der endogenen Depression. Wien Min Wochenschr 97: 190–196

    CAS  Google Scholar 

  • Rupprecht R, Kornhuber J, Wodarz N, Lugauer J, Göbel C, Riederer P, Beckmann H (1991) Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery. J Affect Dis 22: 31–35

    PubMed  CAS  Google Scholar 

  • Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122: 509522

    Google Scholar 

  • Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32: 229–313

    PubMed  CAS  Google Scholar 

  • Tol HHM, Binzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Cive O (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350: 610–614

    PubMed  Google Scholar 

  • Vetutani J, Sulser F (1975) Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain. Nature 257: 495–497

    Google Scholar 

  • Willner P (1985) Antidepressants and serotonergic neurotransmission: an integrative review. Psychopharmacology 85: 387–404

    PubMed  CAS  Google Scholar 

  • Wodarz N, Rupprecht R, Kornhuber J, Schmitz B, Wild K, Riederer P (1992) Cell-mediated immunity and its glococorticoid-sensitivity after clinical recovery from severe major depressive disorder. J Affect Dis 25: 31–38

    PubMed  CAS  Google Scholar 

  • Yamaoka K, Nauba T, Namura S (1988) Direct influence of antidepressants on GTP binding protein of adenylate cyclase in cell membranes of the cerebral cortex of rats. J Neural Transm 71: 165–175

    PubMed  CAS  Google Scholar 

  • Yates M, Leake A, Candy JM, Fairbairn AF, Keith IG, Ferrier IN (1990) 5HT2 receptor changes in major depression. Biol Psychiatry 27: 489–496

    Google Scholar 

  • Young LT, Li PP, Kish SJ, Siu KP, Warsh JJ (1991) Postmortem cerebral cortex Gsa-subunit levels are elevated in bipolar affective disorder. Brain Res 553: 323–326

    Google Scholar 

  • Zemlan FP, Garver DL (1990) Depression and antidepressant therapy: receptor dynamics. Prog Neuropsychopharmacol Biol Psychiatry 14: 503–523

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed, revised. APA, Washington DC

    Google Scholar 

  • Andersen OK, Bergsaker-Aspsy J, Halvorsen L, Giercksky K-E (1984) Doxepin in the treatment of duodenal ulcer. Scand J Gastroenterol 19: 923–925

    Google Scholar 

  • Angst J (1987) Begriff der affektiven Erkrankungen. In: KISKER KP, LAUTER H, Meyer J-E, Müller C, Strömgren E (Hrsg) Psychiatrie der Gegenwart 5. Affektive Psychosen. Springer, Berlin Heidelberg New York Tokyo, S 1–50

    Google Scholar 

  • Angst J, Theobald W (1970) Tofranils (Imipramin). Stämpfli & Cie, Bern

    Google Scholar 

  • Arzneimittelkommission der Deutschen Arzteschaft (1989) Möglicher Mißbrauch des Antidepressivums Doxepin hei Suchtkranken. Dtsch Ärztebl 86: 1467

    Google Scholar 

  • Baldessarini RJ (1989) Current status of antidepressants: clinical pharmacology and therapy. J Clin Psychiatry 50: 117–126

    PubMed  CAS  Google Scholar 

  • Baldessarini RJ, Fleischhacker WW, Speak G (1991) Pharmakotherapie in der Psychiatrie. Thieme, Stuttgart

    Google Scholar 

  • Buller R, Benkert O (1990) Panikattacken und Panikstörungen — Diagnose, Validierung und Therapie. Nervenarzt 61: 647–657

    Google Scholar 

  • Brown-Cartwright D, Brater DC, Barnett CC, Richardson CT (1986) Effect of doxepin on basal gastric acid and salivary secretion in patients with duodenal ulcer. Ann Int Med 104: 204–206

    PubMed  CAS  Google Scholar 

  • Cassano GB, Perugi G, Mcnair DM (1988) Panic disorder: review of the empirical and rational basis of pharmacological treatment. Pharmacopsychiatry 21: 157–165

    PubMed  CAS  Google Scholar 

  • Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 48: 730–738

    Google Scholar 

  • Degkwitz R, Helmchen H, Kockott G, Mombour W (Hrsg) (1980) Diagnoseschlüssel und Glossar psychiatrischer Krankheiten, 5. Aufl, korrigiert nach der 9. Revision der ICD. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Dilling H, Mombour W, Schmidt MH (Hrsg)Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V (F). Huber, Bern Göttingen Toronto

    Google Scholar 

  • Fava GA, Sonino N, Wise TN (1988) Management of depression in medical patients. Psychother Psychosom 49: 81–102

    PubMed  CAS  Google Scholar 

  • Fedoroff JP, Robinson RG (1989) Tricyclic antidepressants in the treatment of poststroke depression. J Clin Psychiatry 50 [Suppl]: 18–23

    PubMed  Google Scholar 

  • Feinmann C (1991) Trizyklische Antidepressiva als Analgetika. In: WORZ R, BASLER H-D (Hrsg) Schmerz und Depression. Deutscher Ärzte Verlag, Köln, S 55–60

    Google Scholar 

  • Fighter MM (1991) Behandlung bulimischer Eßstörungen mit Antidepressiva. In: Hippius H, Ortner M, Ruther E (Hrsg) Psychiatrische Erkrankungen in der ärztlichen Praxis. Springer, Berlin Heidelberg New York Tokyo, S 71–76

    Google Scholar 

  • Gastpar M (1986) Unterschiedliche Pharmakoneffekte bei Angst und Depression: In: Helmchen H, Linden M (Hrsg) Die Differenzierung von Angst und Depression. Springer, Berlin Heidelberg New York Tokyo, S 167–176

    Google Scholar 

  • Huber G (1987) Psychiatrie. Schattauer, Stuttgart HUDSON JI, POPE HG (1989) Psychopharmakologische Behandlung der Bulimia. In: FICHTER M (Hrsg) Bulimia nervosa. Enke, Stuttgart, S 284–292

    Google Scholar 

  • Joyce PR, Paykel ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry 46: 89–99

    PubMed  CAS  Google Scholar 

  • Katon W, Roybyrne PP (1988) Antidepressants in the medically ill: diagnosis and treatment in primary care. Clin Chem 34: 829–836

    PubMed  CAS  Google Scholar 

  • Kielholz P (1965) Psychiatrische Pharmakotherapie in Klinik und Praxis. Huber, Bern

    Google Scholar 

  • Klein DF, Giiielmann R, Quitkin F, Rifkin A (1980) Diagnostic and drug treatment of psychiatric disorders: adults and children. Williams and Wilkins, Baltimore

    Google Scholar 

  • Klerman G (1986) Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. Psychopharmacol Bull 22: 25–29

    PubMed  CAS  Google Scholar 

  • Kramer MS, Vogel WH, Johnson C, Dewey DA et al. (1989) Antidepressants in „depressed“ schizophrenic inpatients. Arch Gen Psychiatry 46: 922–928

    PubMed  CAS  Google Scholar 

  • Kuhn R (1957) Über die Behandlung depressiver Zustände mit einem Iminodibenzylderivat. Schweiz Med Wochenschr 87: 1135–1140

    PubMed  CAS  Google Scholar 

  • Lacey JH, Crisp AH (1980) Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. Postgrad Med J 56: 79–85

    PubMed  Google Scholar 

  • Leber P (1986) The placebo control in clinical trials (a view from the FDA). Psychopharmacol Bull 22: 30–32

    PubMed  CAS  Google Scholar 

  • Liebowitz MR (1989) Antidepressants in panic disorders. Br J Psychiatry [Suppl 61: 46–52

    Google Scholar 

  • Lydiard RB, Ballinger JC (1987) Antidepressants in panic disorder and agoraphobia. J Affect Disord 13: 153–168

    PubMed  CAS  Google Scholar 

  • Magni G, Conlon P, Arsie D (1987) Tricyclic antidepressants in the treatment of cancer pain: a review. Pharmacopsychiatry 20: 160–164

    PubMed  CAS  Google Scholar 

  • Maier W, Benkert O (1987) Methodenkritik des Wirksamkeitsnachweises antidepressiver Pharmakotherapie. Nervenarzt 58: 595–602

    Google Scholar 

  • Marneros A, Tsuang MT (eds) (1986) Schizoaffective psychoses. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Mctavish D, Benfield P (1990) Clomipramine-an overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 39: 136–153

    PubMed  CAS  Google Scholar 

  • Moller HJ, Morin C (1989) Behandlung schizo-depressiver Syndrome mit Antidepressiva. In: Marneros A (Hrsg) Schizoaffektive Psychosen. Springer, Berlin Heidelberg New York Tokyo, S 159–178

    Google Scholar 

  • Modigh K (1987) Antidepressant drugs in anxiety disorders. Acta Psychiatr Scand 335 [Suppl]: 57–74

    CAS  Google Scholar 

  • Morris JB, Beck AT (1974) The efficacy of antidepressant drugs. Arch Gen Psychiatry 30: 667–674

    PubMed  CAS  Google Scholar 

  • Murphy DL, Siever LJ, Insel TR (1985) Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient populations. Prog Neuropsychopharmacol Biol Psychiatry 9: 3–13

    CAS  Google Scholar 

  • Nelson JC, Mazure CM, Jatlow PI (1990) Does melancholia predict response in major depression? J Affect Disord 18: 157–165

    PubMed  CAS  Google Scholar 

  • Nutzinger DO, de Zwaan M, Schönbeck G (1991) Serotonin und Eßstörungen. Nervenarzt 62: 198–201

    PubMed  CAS  Google Scholar 

  • Parker G, HALL W, Boyce P et al. (1991) Depression sub-typing: unitary, binary or arbitrary? Aust NZ J Psychiatry 25: 63–76

    CAS  Google Scholar 

  • Paykel ES, Hollyman JA, Ereeling P, Sedgwick P (1988) Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord 14: 83–95

    PubMed  CAS  Google Scholar 

  • Pfaffenrath V, Diener HC, Isler H et al (1993) Wirksamkeit und Verträglichkeit von Amitriptylinoxid beim chronischen Spannungskopfschmerz–Eine multizentrische Doppelblindstudie versus Amitriptylin versus Plazebo. Nervenarzt 64: 114–120

    PubMed  CAS  Google Scholar 

  • Philipp M, Beck V, Glocke M, Metz K, Scherhag R, Schmidt R (1985) Vorhersagbarkeit des Therapieansprechens depressiver Patienten auf Doxepin. In: Philipp M (Hrsg) Grundlagen und Erfolgsvorhersage der ambulanten Therapie mit Antidepressiva. Springer, Berlin Heidelberg New York Tokyo, S 29–45

    Google Scholar 

  • Puszia SR (1987) Tricyclic antidepressants in the treatment of children with attention deficit disorder. J Am Acad Child Adolesc Psychiatry 26: 127–132

    Google Scholar 

  • Pope HG, Hudson JI (1982) Treatment of bulimia with antidepressants. Psychopharmacology 78: 176–179

    PubMed  Google Scholar 

  • Rapoport JL (1991) Medikamentöse Behandlung der Zwangserkrankung. Nervenarzt 62: 318320

    Google Scholar 

  • Rickels K (1986) Use of placebo in clinical trials. Psychopharmacol Bull 22: 19–24

    PubMed  CAS  Google Scholar 

  • Schmidt LG, Grohmann R, Müller-Oerlinghausen B, Poser W, Rüther E, Wolf B (1990) Mißbrauch von Antidepressiva bei Suchtkranken. Dtsch Ärztebl 87: 92–96

    Google Scholar 

  • Schulz E, Remschidt H (1990) Die Stimulanzien–Therapie des hyperkinetischen Syndroms im Kindes-und Jugendalter. Z Kinder Jugendpsychiat 18: 157–166

    CAS  Google Scholar 

  • Small GW (1989) Tricyclic antidepressants for medically ill geriatric patients. J Clin Psychiatry 50 [Suppll: 27–31

    Google Scholar 

  • Stimmel GL, Escobar JI (1986) Antidepressants in chronic pain: a review of efficacy. Pharmacotherapy 6: 262–267

    PubMed  CAS  Google Scholar 

  • Sundblad C, Modigh K, Andersch B, Eriksson E (1992) Clomipramine effectively reduces pre- menstrual irritability and dysphoria: a placebo- controlled trial. Acta Psychiatr Scand 85: 39–47

    PubMed  CAS  Google Scholar 

  • Swedo SE, Leonard HL, Rapoport JL, Lenane MC et al. (1989) A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med 321: 497–501

    PubMed  CAS  Google Scholar 

  • Weiss RD, Mirin SM (1989) Tricyclic antidepressants in the treatment of alcoholism and drug abuse. J Clin Psychiatry 50 [Suppll: 4–9

    Google Scholar 

  • Wörz R, Basler H-D (Hrsg) (1991) Schmerz und Depression. Deutscher Ärzte Verlag, Köln

    Google Scholar 

  • Angst J, Bech P, Boyer P, Bruinvels J, Engel E et al. (1989) Consensus Conference on the Methodology of Clinical Trials of Antide- pressants, Zurich, March 1988. Report of the Consensus Comittee. Pharmacopsychiatry 22: 3–7

    Google Scholar 

  • Appleton WS (1982) Fourth psychoactive drug usage guide. J Clin Psychiatry 43: 12–27

    PubMed  CAS  Google Scholar 

  • Asberg M, Crönholm B, Sjöqvist F, Tuck D (1971) Relationship between plasma level and thera- peutic effect of nortriptyline. Br Med J 3: 331–334

    PubMed  CAS  Google Scholar 

  • Baumann P (1990) Pharmakokinetische Aspekte der Therapieresistenz mit Antidepressiva. In: MÖLLER HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokyo, S 85–96

    Google Scholar 

  • Beckmann H (1981) Die medikamentöse Therapie der Depression. Nervenarzt 52: 135–146

    PubMed  CAS  Google Scholar 

  • Brandon S (1986) Management of depression in general practice.Br Med J 292: 287–289

    CAS  Google Scholar 

  • Bridges PK (1983),,… and a small dose of an antidepressant might help“. Br J Psychiatry 142: 626–628

    Google Scholar 

  • Buller R, Benkert O (1990) Panikattacken und Panikstörungen — Diagnose, Validierung und Therapie. Nervenarzt 61: 647–657

    Google Scholar 

  • Oliveira IR, Prado-Lima PAS, Samuel-Lajeunesse B (1989a) Monitoring of tricyclic antidepressant plasma levels and clinical response: a review of the literature. Part I. Psychiatr Psychobiol 4: 43–60

    Google Scholar 

  • Oliveira IR, Prado-Lima PAS, Samuel-Lajeunesse B (1989b) Monitoring of tricyclic antidepressant plasma levels and clinical response: a review of the literature. Part II. Psychiatr Psychobiol 4: 81–90

    Google Scholar 

  • Eggers C (1992) Psychopharmakotherapie bei Kindern und Jugendlichen. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd. 1. Allgemeine Grundlagen der Pharmakopsychiatrie. Springer, Wien New York, S 381–390

    Google Scholar 

  • Feinmann C (1991) Trizyklische Antidepressiva als Analgetika. In: Wörz R, Basler H-D (Hrsg) Schmerz und Depression. Deutscher Ärzte Verlag, Köln, S 55–60

    Google Scholar 

  • Guthrie S, Lane EA, Linnoila M (1987) Monitoring of plasma drug concentrations in clinical psychopharmacology. In: Meltzer HY (ed) Psychopharmacology. The third generation of progress. Raven Press, New York, pp 13251338

    Google Scholar 

  • Keller MG, Klerman GL, Lavori PW, Fawcett JA, Coryell W, Endicotf J (1982) Treatment received by depressed patients. J Am Med Assoc 248: 1848–1855

    CAS  Google Scholar 

  • Laux G (1990) Dosiserhöhung, Titration eines optimalen Wirkspiegels und Infusionstherapie als effiziente Möglichkeiten der Behandlung therapieresistenter Depressionen mit Antidepressiva. In: Moller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokyo, S 99–112

    Google Scholar 

  • Linden M (1987) Phase-IV-Forschung. Antidepressiva in der Nervenarztpraxis. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Linden M, Schüssler G (1985) Low dosage antidepressant treatment in private psychiatric practice — a replication study. Pharmacopsychiatry 18: 44 45

    Google Scholar 

  • Preskorn SH (1989) Tricyclic antidepressants: the whys and hows of therapeutic drug monitoring. J Clin Psychiatry 50 [Suppl]: 34 42

    Google Scholar 

  • Quitkin FM (1985) The importance of dosage in prescribing antidepressants. Br J Psychiatry 147: 593–597

    PubMed  CAS  Google Scholar 

  • Risch SC, Huey LY, Janowsky DS (1979a) Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature. Part I. J Clin Psychiatry 40: 4–16

    Google Scholar 

  • Risen SC, Huey LY, Janowsky DS (19796) Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature. Part II. J Clin Psychiatry 40: 58–69

    Google Scholar 

  • Schüssler G (1987) Wie sind Antidepressiva in der Praxis zu dosieren? Wie ist die Einnahmesicherheit in der ambulanten Behandlung zu gewährleisten? In: Hippius H, Wither E (Hrsg) Antidepressiva und Depressionsbehandlung in der ärztlichen Praxis. Springer, Berlin Heidelberg New York Tokyo, S 30–33

    Google Scholar 

  • Simpson GM, Lee JH, Cuculica A, Kellner R (1976) Two dosages of imipramine in hospitalised endogenous and neurotic depressives. Arch Gen Psychiatry 33: 1093–1102

    PubMed  CAS  Google Scholar 

  • Task Force on The Use of Laboratory Tests in Psychiatry (1985) Tricyclic antidepressants–blood level measurements and clinical outcome: an APA task force report. Am J Psychiatry 142: 155–162

    Google Scholar 

  • Tyrer P (1987) Drug treatment of psychiatric patients in general practice. Br Med J 2: 1008–1010

    Google Scholar 

  • Brunt N (1983) A clinical utility of tricyclic antidepressant blood levels: a review of the literature. Ther Drug Monit 5: 1–10

    PubMed  Google Scholar 

  • Watt DC, Crammer JL, Elkes A (1972) Metabolism, anticholinergic effects, and therapeutic outcome of desmethyl-imipramine in depressive illness. Psychol Med 2: 397–405

    PubMed  CAS  Google Scholar 

  • Who (World Health Organization) (1986) Dose effects of antidepressant medication in different populations. A World Health Organization Collaborative Study. J Affect Disord [Suppl] 2: 1–67

    Google Scholar 

  • Woggon B (1990) Frühansprechen auf Antidepressiva: die prognostische Bedeutung der Probetherapie. In: Moller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokyo, S 33–39

    Google Scholar 

  • Wörz R, Basler H-D (Hrsg) (1991) Schmerz und Depression. Deutscher Ärzte Verlag, Köln

    Google Scholar 

  • Alßertini RS, Pender TM (1978) Agranulocytosis associated with tricyclics. J Clin Psychiatry 39: 483–485

    Google Scholar 

  • Bergener M, Friedel B (Hrsg) (1987) Unfall-und Sicherheitsforschung Straßenverkehr. Psychopharmaka und Verkehrssicherheit. Verlag für neue Wissenschaft, Bremerhaven

    Google Scholar 

  • Blackwell B (1981) Adverse effects of antidepressant drugs. Part 1. Monoamine oxidase inhibitors and tricyclics. Drugs 21: 201–219; Part 2. Second generation antidepressants and rational decision making in antidepressant therapy. Drugs 21: 273

    CAS  Google Scholar 

  • Boning J (1980) Spezielle Gedächtnis-und Bewußtseinsstörungen unter der Therapie mit Antidepressiva und endogener Depression. Pharmacopsychiatry 13: 72–78

    CAS  Google Scholar 

  • Boning J (1982) Zentralmotorische und extrapyramidale Nebenwirkungen unter Therapie mit Antidepressiva. Fortschr Neurol Psychiat 50: 35–47

    PubMed  CAS  Google Scholar 

  • Cassidy SL, Henry JA (1987) Fatal toxicity of antidepressant drugs in overdose. Br Med J 295: 1021–1024

    CAS  Google Scholar 

  • Cohen LS (1989) Psychotropic drug use in pregnancy. Hosp Commun Psychiatry 40: 5–66

    Google Scholar 

  • Cole JO, Bodkin JA (1990) Antidepressant drug side effects. J Clin Psychiatry 51 [Suppl 11: 21–26

    Google Scholar 

  • Committee on Safety of Medicines (1985) Adverse reactions to antidepressants. Br Med J 291: 16–38

    Google Scholar 

  • Crome P (1990) Adverse effects of antidepressants in the elderly. In: Leonard B, Spencer P (eds) Antidepressants: thirty years on. CNS ( Clinical Neuroscience) Publishers, London, pp 465–474

    Google Scholar 

  • Curran HV, Sakulskriprong M, Lader M (1988) Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology 95: 520–527

    PubMed  CAS  Google Scholar 

  • Dilsaver SC, Greden JF (1984) Antidepressant withdrawal phenomena. Biol Psychiatry 19: 237–256

    PubMed  CAS  Google Scholar 

  • Dolle W, Müller-Oerlinghausen B, Schwabe K (Hrsg) (1986) Grundlagen der Arzneimitteltherapie. Wissenschaftsverlag, Mannheim Wien Zürich

    Google Scholar 

  • Edwards JG, Long SK, Sedgwick EM, Wheal HV (1986) Antidepressants and convulsive seizures: clinical, eletroencephalographic, and pharmacological aspects. Clin Neuropharmacol 9: 329–360

    PubMed  CAS  Google Scholar 

  • Fann W, Sullivan IL, Richman B (1976) Dyskinesia associated with tricyclic antidepressants. Br J Psychiatry 128: 490–493

    PubMed  CAS  Google Scholar 

  • Frommer DA, Kulig KE, Marx JA, Rumack B (1987) Tricyclic antidepressant overdose. J Am Med Assoc 257: 521–526

    CAS  Google Scholar 

  • Garvey MJ, Tollefson GD (1987) Occurence of myoclonus in patients treated with cyclic antidepressants. Arch Gen Psychiatry 44: 269–272

    PubMed  CAS  Google Scholar 

  • Girard M, Biscos-Garreau M (1989) Reliability of data on haematotoxicity of antidepressants. A retrospective assessment of haematological monitoring in clinical studies on tricyclics. J Affect Disord 17: 153–158

    Google Scholar 

  • Glassman AH (1984) The newer antidepressant drugs and their cardiovascular effects. Psychopharmacol Bull 20: 272–279

    PubMed  CAS  Google Scholar 

  • Glassmann AH, Bigger JT JR (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 38: 815–820

    Google Scholar 

  • Gottfries CG (1981) Influence of depression and antidepressants on weight. Acta Psychiatr Scand 63: 353–360

    Google Scholar 

  • Harris B, Young J, Heykes B (1984) Changes occurring in appetite and weight during short-term antidepressant treatment. Br J Psychiatry 145: 645–648

    PubMed  CAS  Google Scholar 

  • Henry JA (1990) Toxic effects of antidepressants. In: LEONARD B, SPENCER P (eds) Antidepressants: thirty years on. CNS ( Clinical Neuroscience) Publishers, London, pp 385–397

    Google Scholar 

  • Hindmarch I (1986) The effects of psychoactive drugs on car handling and related psychomotor ability: a Ieview. In: O’hanlon JF, Gier JJ (eds) Drugs and driving. Taylor and Francis, London, pp 71–82

    Google Scholar 

  • Hindmarch I, Barwell F, Alford C (1990) Behavioural toxicity of antidepressants. In: LEONARD B, SPENCER P (eds) Antidepressants: thirty years on. CNS, London, pp 403–409

    Google Scholar 

  • Jackson WK, Roose SP, Glassman AH (1987) CaIdiovalcular toxicity and tricyclic antidepressants. Biomed Pharmacother 41: 377–382

    PubMed  CAS  Google Scholar 

  • Jabbari B, Bryan GE, Marsh EE et al. (1982) Incidence of seizures with tricyclic and tetracyclic antidepressants. Arch Neurol 42: 480–481

    Google Scholar 

  • Jan NN, Wise TN (1988) Antidepressants and inhibited female orgasm: a literature review. J Sex Marital Ther 14 (4): 279–284

    Google Scholar 

  • Koeppen D, Mohr R, Streichenwein S (1989) Assessment of adverse drug events during the clinical investigation of a new drug. Pharmacopsychiatry 22: 93–98

    PubMed  CAS  Google Scholar 

  • Lewis JL, winokur G (1982) The induction of mania. Arch Gen Psychiatry 39: 303

    PubMed  CAS  Google Scholar 

  • Lieberman E, Stoudemire A (1987) Use of tricyclic antidepressants in patients with glaucoma. Psychosomatics 28: 145–148

    PubMed  CAS  Google Scholar 

  • Mirin SM, Schatzberg AF, Creasey DE (1981) Mania after tricyclic antidepressant withdrawal. Am J Psychiatry 138: 87

    PubMed  CAS  Google Scholar 

  • Mitchell JE, Popkin MK (1983) Antidepressant drug therapy and sexual dysfunction in men: a review. J Clin Psychopharmacol 3: 76–79

    PubMed  CAS  Google Scholar 

  • Möller HJ, Meier K, Wernicke T (1988) Empirical investigation on the risk of agranulocytosis/ leucopenia under medication with antidepressants. Pharmacopsychiatry 21: 304–305

    PubMed  Google Scholar 

  • Pentel PR, Benowitz NL (1986) Tricyclic antidepressant poisoning: management of arrhythmias. Med Toxicol 1: 101–121

    PubMed  CAS  Google Scholar 

  • Pinder RIVI (1988) The benefits and risks of antidepressant drugs. Human Psychopharmacol 3: 73–86

    Google Scholar 

  • Preskorn SH, Jerkovich GS (1990) Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring. J Clin Psychopharmacol 10: 88–95

    PubMed  CAS  Google Scholar 

  • Ragheb M (1981) Drug interactions in psychiatric practice. Int Pharmacopsychiatryl6: 92–118

    Google Scholar 

  • Rawlins MD (1981) Clinical pharmacology: adverse reactions to drugs. Br Med J 282: 974–976

    CAS  Google Scholar 

  • Rhoades HM, Overall JE (1984) Side effect potentials of different antipsychotic and antidepressant drugs. Psychopharmacol Bull 20: 83–88

    PubMed  CAS  Google Scholar 

  • Roose SP, Glassman AH, Giardina EGV, Walsh BT, Woodring S, Bigger T (1987) Tricyclic antidepressants in depressed patients with cardiac conduction disease. Arch Gen Psychiatry 44: 273–275

    PubMed  CAS  Google Scholar 

  • Schmidt LG, Grohmann R, Müller-Oerlinghausen B, Ochsenfarth H, Schonhofer PS (1986) Adverse drugs reactions to first and second-generation antidepressants: a critical evaluation of drugs surveillance data. Br J Psychiatry 148: 38–43

    PubMed  CAS  Google Scholar 

  • Schmidt LG, Schüssler G, Linden M, Müller-Oerlinghausen B (1988) Zur Häufigkeit und Therapierelevanz unerwünschter Wirkungen von Antidepressiva im Rahmen der ambulanten nervenärztlichen Behandlung. Fortschr Neurol Psychiat 56: 111–118

    PubMed  CAS  Google Scholar 

  • Schneider H (1985) Medikamente in der Schwangerschaft. Therapiewoche 35: 645–654

    Google Scholar 

  • Snyder SH, Peroutka SJ (1985) Antidepressants and neurotransmitter receptors. In: Post RM, Ballenger JC (eds) Neurobiology of mood disorders. Williams and Wilkins, Baltimore London, p 686–697

    Google Scholar 

  • Strauss B, Gross J (1984) Auswirkungen psychopharmakologischer Behandlung auf die sexuellen Funktionen. Fortschr Neurol Psychiat 52: 293–301

    PubMed  CAS  Google Scholar 

  • Tesar GE, Rosenbaum JF, Biedeman J, Weilburg JB, Pollack MH, Gross CC, Falk WE, Gastfriend DR, Zusky PM, Bouckoms A (1987) Orthostatic hypotension and antidepressant pharmacotherapy. Psychopharmacol Bull 23: 182–186

    PubMed  CAS  Google Scholar 

  • Thomann P, Hess R (1981) Toxicology of antidepressant drugs. In: HOFFMEISTER F, STILLE G (eds) Psychotropic agents. Part 1. Antipsychotics and antidepressants. Springer, Berlin Heidelberg New York, p 527

    Google Scholar 

  • Veith RC, Raskind MA, Caldwell JH, Barnes RF, Bumbrecht G, Ritchie JL (1982) Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease. N Engl J Med 306: 954–959

    PubMed  CAS  Google Scholar 

  • Vincent PC (1986) Drug-induced aplastic anaemia and agranulocytosis. Incidence and mechanisms. Drugs 31: 52–63

    Google Scholar 

  • Warnock JK, Knesevich JW (1988) Adverse cutaneous reactions to antidepressants. Am J Psychiatry 145: 4–25

    Google Scholar 

  • Weeke A, Juel K, Vaeth M (1987) Cardiovascular death and manic-depressive psychosis. J Affect Disord 13: 287–292

    PubMed  CAS  Google Scholar 

  • Wehr TA, Goodwin FK (1987) Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144: 1403–1411

    PubMed  CAS  Google Scholar 

  • Zubenko GS, Cohen BM, Lipinski JF (1987) Antidepressant-related akathisia. J Clin Psychopharmacol 7: 254–257

    PubMed  CAS  Google Scholar 

  • Abernethy DR, Greenblatt DJ, Shader RI (1984) Imipramine — cimetidine interaction: impairment of clearance and enhanced bioavailability. J Pharmacol Exp Ther 229: 702–705

    PubMed  CAS  Google Scholar 

  • Alexanderson B, Evans DA, Sjoqvist F (1969) Steady state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br Med J 4: 764

    PubMed  CAS  Google Scholar 

  • Ananth J, Luchins D et al. (1977) A review of combined tricyclic and MAOI therapy. Compr Psychiatry 18: 121–134

    Google Scholar 

  • Austin LS, Arana GW, Melvin JA (1990) Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. J Clin Psychiatry 51: 344–345

    PubMed  CAS  Google Scholar 

  • Bergstrom RF, Peyton AL, Lemberger L (1992) Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction. Clin Pharmacol Ther 51: 239–248

    Google Scholar 

  • Bernstein M (1990) Pimozide and tricyclics (I). Hosp Community Psychiatry 41: 454

    PubMed  CAS  Google Scholar 

  • Bigger JT, Giardina EV, Perel JM et al. (1977) Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med 296: 206

    PubMed  CAS  Google Scholar 

  • Blazer HG, Federspiel CF, Ray WA et al. (1983) The risk of anticholinergic toxicity in the elderly: a study prescribing practices in two populations. J Gerontol 38: 31–35

    PubMed  Google Scholar 

  • Boakes AJ, Laurence DR, Teoh PC et al. (1973) Interactions between sympathomimetic amines and antidepressant agents in man. Br Med J 1: 311–315

    PubMed  CAS  Google Scholar 

  • Briant RH, Rub JL, Dollery CT (1973) Interaction between clonidine and desipramine in man. Br Med J 1: 522–523

    Google Scholar 

  • Brown CS, Wells BG, Cold JA et al. (1990) Possible influence of carbamazepine on plasma imipramine concentrations in children with attention-deficit hyperactivity disorder. J Clin Psychopharmacol 10: 359–362

    Google Scholar 

  • Bruckner HW, Schleifer SJ (1983) Orthostatic hypotension as a complication of hexamethylmelamine antidepressant interaction. Cancer Treat Rep 67: 516

    PubMed  CAS  Google Scholar 

  • Ciraulo DA, Barnhill JG, Boxenbaum H (1985) Pharmacokinetic interaction between disulfiram and antidepressants. Am J Psychiatry 142: 1373–1374

    PubMed  CAS  Google Scholar 

  • Ciraulo DA, Barnhill JG, Jaffe JH (1988) Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers. Clin Pharmacol Ther 43: 509–518

    PubMed  CAS  Google Scholar 

  • Ciraulo DA, Shader RI, Greenblatt DJ, Creelman W (eds) (1989) Drug interactions in psychiatry. Williams and Wilkins, Baltimore

    Google Scholar 

  • Edelbroek PM, Zitman FG et al. (1987) Therapeutic drug monitoring of amitriptyline: impact of age, smoking and contraceptives on drug and metabolite levels in bulimic women. Clin Chim Acta 165: 177–187

    PubMed  CAS  Google Scholar 

  • Edwards RP, Miller RD, Roizen MF et al. (1979) Cardiac responses to imipramine and pancuronium during anaesthesia with halothane or enflurane. Anesthesiology 50: 421–425

    PubMed  CAS  Google Scholar 

  • Flemenbaum A (1972) Hypertensive episodes after adding methylphenidate (Ritalin®) to tricyclic antidepressants. Psychosomatics 13: 265

    PubMed  CAS  Google Scholar 

  • Goodwin FK, Prange AJ, Post RM et al. (1982) Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders. Am J Psychiatry 139: 34–38

    PubMed  CAS  Google Scholar 

  • Gram LF, Brosen K (1989) Inhibitors of the microsomal oxidation of psychotropic drugs: selectivity and clinical significance. In: DAHL SG, GRAM LF (eds) Clinical pharmacology in psychiatry. From molecular studies to clinical reality. Springer, Berlin Heidelberg NewYork Tokyo, pp 172–180

    Google Scholar 

  • Gundert-Remy U, Amann E, Hildebrandt R et al. (1983) Lack of interaction between the tetra-cyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine. Eur J Clin Pharmacol 25: 595–599

    PubMed  CAS  Google Scholar 

  • Joe A, Annoni F, Bianchetti A (1968) Metabolic effects induced by the interaction of reserpine with desipramine. J Pharm Pharmacol 20: 862–866

    Google Scholar 

  • Kantor SJ, Glassman AH, Bigger JT et al. (1978) The cardiac effects of therapeutic plasma concentrations of imipramine. Am J Psychiatry 135: 534

    PubMed  CAS  Google Scholar 

  • Khurana RC (1972) Estrogen — imipramine interaction. JAMA 222: 702

    PubMed  CAS  Google Scholar 

  • Koch-Weser J, Sellers EM (1971) Drug interactions with coumarin anticoagulants, part 2. N Engl J Med 285: 547–558

    CAS  Google Scholar 

  • Korn A, Eichler HG, Fischbach R et al. (1986) Moclobemide, a new reversible MAO inhibitor — interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients. Psychopharmacology 88: 153–157

    PubMed  CAS  Google Scholar 

  • Landauer AA, Milner G, Patman J (1969) Alcohol and amitriptyline effects on skills related to driving behaviour. Science 163: 1467

    PubMed  CAS  Google Scholar 

  • Lasswell WL, Weber SS, Wilkins JM (1984) In vitro interaction of neuroleptics and tricyclic antidepressants with coffee, tea, and gallotannic acid. J Pharm Sci 73: 1056–1058

    PubMed  CAS  Google Scholar 

  • Leishman AWD, Matthews AL, Smith AJ (1963) Antagonism of guanethidine by imipramine. Lancet ii: 112

    Google Scholar 

  • Linnoila M, George L, Guthrie S et al. (1981) Effect of alcohol consumption and cigarette smoking on antidepressant levels of depressed patients. Am J Psychiatry 138: 841–842

    PubMed  CAS  Google Scholar 

  • Linnoila M, George L, Guthrie S (1982) Interaction between antidepressants and perphenazine in psychiatric inpatients. Am J Psychiatry 139: 1329–1331

    PubMed  CAS  Google Scholar 

  • Maany I, Hayashida M, Pfeffer SL et al. (1982) Possible toxic interaction between disulfiram and amitriptyline. Arch Gen Psychiatry 39: 743–744

    PubMed  CAS  Google Scholar 

  • Meyer JF, Mcallister CK, Goldberg L (1970) Insidious and prolonged antagonism of guanethidine by amitriptyline. JAMA 213: 1487

    PubMed  CAS  Google Scholar 

  • Milner G (1969) Gastro-intestinal side effects and psychotropic drugs. Med J Aust 2: 153

    PubMed  CAS  Google Scholar 

  • Moody JP, Whyte SF, Macdonald AJ et al. (1977) Pharmacokinetic aspects of protriptyline plasma levels. Eur J Clin Pharmacol 11: 51–56

    Google Scholar 

  • Morgan JP, Rivera-Calimlim L, Messiha F et al. (1975) Imipramine - mediated interference with levodopa absorption from the gastrointestinal tract in man. Neurology 25: 1029

    PubMed  CAS  Google Scholar 

  • Prange AJ, Wilson IC, Rabon AM et al. (1969) Enhancement of imipramine-antidepressant activity by thyroid hormone. Am J Psychiatry 126: 457

    PubMed  CAS  Google Scholar 

  • Razani J, White KL, White J et al. (1983) The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. Arch Gen Psychiatry 40: 657–661

    PubMed  CAS  Google Scholar 

  • Rivera-Calimlim L, Nasrallah H, Strauss J et al. (1976) Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels. Am J Psychiatry 133: 646–652

    PubMed  CAS  Google Scholar 

  • Sandyk R, Gillman MA (1985) Baclofen - induced memory impairment. Clin Neuropharmacol 8: 294

    PubMed  CAS  Google Scholar 

  • Schuckit M, Robins E, Feighner J (1971) Tricyclic antidepressant and monoamine oxidase inhibitors. Combination therapy in the treatment of depression. Arch Gen Psychiatry 24: 509–514

    Google Scholar 

  • Seppäla T, Stromberg C, Bergman I (1984) Effects of zimeldine, mianserin and amitriptyline on psychomotor skills and their interaction with ethanol. A placebo cross-over study. Eur J Clin Pharmacol 27: 181–189

    Google Scholar 

  • Skjelbo E, Brosen K (1992) Inhibitors of imipramine metabolism by human liver microsomes. Br J Clin Pharmacol 34: 256–261

    PubMed  CAS  Google Scholar 

  • Spiker DG, Pugh DD (1976) Combining tricyclic and monoamine oxidase inhibitor antidepressants. Arch Gen Psychiatry 33: 828–830

    PubMed  CAS  Google Scholar 

  • Spina E, Campo GM, Avenoso A, Pollicino. MA, Caputi AP (1992) Interaction between fluvoxamine and imipramine/desipramine in four patients. Ther Drug Monit 14: 194–196

    PubMed  CAS  Google Scholar 

  • Sutherland DL, Remillard AJ, Haight KR et al. (1987) The influence of cimetidine versus ranitidine on doxepin pharmacokinetics. Eur J Clin Pharmacol 32: 159–164

    PubMed  CAS  Google Scholar 

  • Vaughan DA (1988) Interaction of fluoxetine with tricyclic antidepressants. Am J Psychiatry 145: 1478

    PubMed  CAS  Google Scholar 

  • Weber E (Hrsg) (1991) Taschenbuch der unerwünschten Arzneiwirkungen. Fischer, Stuttgart

    Google Scholar 

  • Wharton RN, Perel JM, Dayton PG et al. (1971) A potential clinical use for methylphenidate with tricyclic antidepressants. Am J Psychiatry 127: 1619–1625

    PubMed  CAS  Google Scholar 

  • Zimmer R, Gieschke R, Fischbach R et al. (1990) Interaction studies with moclobemide. Acta Psychiatr Scand 360 [Suppll: 84–86

    Google Scholar 

  • Boston Collaborative Drug Surveillance Pro Gram (1972) Adverse reactions to the tricyclic antidepressant drugs. Lancet is 529–531

    Google Scholar 

  • Edwards JG (1985) Antidepressants and seizures: epidemiological and clinical aspects. In: TRIMBLE MR (ed) The psychopharmacology of epilepsy. Wiley, Chichester, pp 119–139

    Google Scholar 

  • Glassman AH, Bigger JT (1981) Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 38: 815–820

    PubMed  CAS  Google Scholar 

  • Grohmann R, Hippius H, Müller-Oerlinghausen B, Rüther E, Scherer J, Schmidt LG, Strauss A, Wolf B (1984) Assessment of adverse drug reactions in psychiatric hospitals. Eur J Clin Pharmacol 26: 727–734

    PubMed  CAS  Google Scholar 

  • Hartl O, Dejaco R, Friedl H, Pürgyi P (1972) EKG-Veränderungen unter Infusionsbehand- lung mit trizyklischen Antidepressiva. Phar- makopsychiatrie 5: 20–25

    Google Scholar 

  • Helmchen H, Hippius H, Müller-Oerlinghausen B, Ruttier E (1985) Arzneimittel-Überwachung in der Psychiatrie. Nervenarzt 56: 12–18

    PubMed  CAS  Google Scholar 

  • Hobi V (1992) Psychopharmaka und Fahrtauglichkeit. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd 1. Allgemeine Grundlagen der Pharmakopsychiatrie. Springer, Wien New York, S 335–352

    Google Scholar 

  • Inman WHW (1988) Blood disorders and suicide in patients taking mianserin or amitriptyline. Lancet 9: 90–93

    Google Scholar 

  • Linden M (1987) Phase-IV-Forschung. Antidepressiva in der Nervenarztpraxis. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Linden M (1991) Antidepressiva-Langzeitmedikation. In: Hippius H, Ortner M, Rüther E (Hrsg) Psychiatrische Erkrankungen in der ärztlichen Praxis. Springer, Berlin Heidelberg New York Tokyo, S 1–11

    Google Scholar 

  • Luchins DJ (1983) Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants. Am J Psychiatry 140: 1006–1009

    PubMed  CAS  Google Scholar 

  • Luchins DJ, Oliver AP, Wyatt RJ (1984) Seizures with antidepressants: an in vitro technique to assess relative risk. Epilepsia 25: 25–32

    Google Scholar 

  • Möller HJ, Meier K, Wernicke T (1988) Empirical investigation on the risk of agranulocytosis/ leucopenia under medication with antidepressants. Pharmacopsychiatry 21: 304–305

    PubMed  Google Scholar 

  • Schmidt LG, Schüssler G, Linden M, Muller-Oerlinghausen B (1985) Unerwünschte Arznei- mittelwirkungen von Psychopharmaka in der nervenärztlichen Praxis. Nervenarzt 56: 19–24

    PubMed  CAS  Google Scholar 

  • Schmidt LG, Grohmann R, Müller-Oerlinghausen B, Ochsenfahrt H, Schönhöfer PS (1986) Adverse drug reactions to first-and second-generation antidepressants: a critical evaluation of drug surveillance data. Br J Psychiatry 148: 38–43

    PubMed  CAS  Google Scholar 

  • Spiess-Kiefer C, Grohmann R (1987) Psychopharmaka-induzierte Blutbildveränderungen. Minch Med Wochenschr 129: 173–175

    Google Scholar 

  • Tornatore FL, Sramek JJ, Okeya BL, Pi EH (1991) Unerwünschte Wirkungen von Psychopharmaka. Thieme, Stuttgart

    Google Scholar 

  • Ancill RJ, Holliday SG (1990) Treatment of depression in the elderly: a Canadian view. Prog Neuropsychopharmacol Biol Psychiatry 14: 655–661

    PubMed  CAS  Google Scholar 

  • Angst J, Bech P, Boyer P, Bruinvels J, Engel E et al. (1989) Consensus Conference on the Methodology of Clinical Trials of Antidepressants, Zurich, March 1988. Report of the Consensus Committee. Pharmacopsychiatry 22: 3–7

    Google Scholar 

  • Ayd FJ (1984) Long-term treatment of chronic depression: 15-year experience with Doxepin HC1. J Clin Psychiatry 45: 3–39

    Google Scholar 

  • Beck AT (1991) Cognitive therapy. A 30-year retrospective. Am Psychol 46: 368–375

    Google Scholar 

  • Beckmann H, Goodwin FK (1980) Urinary MHPG in subgroups of depressed patients and normal controls. Neuropsychobiology 6: 91–100

    PubMed  CAS  Google Scholar 

  • Beckmann H, Moises HW (1982) The cholinolytic biperiden in depression. Arch Psychiatr Nervenkr 231: 213–220

    PubMed  CAS  Google Scholar 

  • Bergener M (Hrsg) (1989) Depressive Syndrome im Alter. Thieme, Stuttgart

    Google Scholar 

  • Bielski RJ, Friedel RO (1976) Prediction of tricyclic antidepressant response. Arch Gen Psychiatry 33: 1479–1489

    PubMed  CAS  Google Scholar 

  • Blackwell B (1982) Antidepressant drugs: side-effects and compliance. J Clin Psychiatry 43: 14–18

    PubMed  CAS  Google Scholar 

  • Brown RP, Frances A, Kocsis JH, Mann JJ (1982) Psychotic vs. nonpsychotic depression: comparison of treatment response. J Nery Ment Dis 170: 635–637

    CAS  Google Scholar 

  • Buist A, Norman TR, Dennerstein L (1990) Breast-feeding and the use of psychotropic medication: a review. J Affect Disord 19: 197–206

    PubMed  CAS  Google Scholar 

  • Cassano GB, Placidi GF (1984) The long-term course of unipolar depressions: implications for antidepressant treatments. In: Kryspinexner K, HINTERHUBER H, SCHUBERT H (Hrsg) Langzeittherapie psychiatrischer Erkrankungen. Schattauer, Stuttgart, S 17–31

    Google Scholar 

  • Christensen P, Lolk A, Gram LF, Kragh-Sorensen P, Pedersen OL, Nielsen S (1989) Cortisol and treatment of depression: predictive value of spontaneous and suppressed cortisol levels and course of spontaneous plasma cortisol. Psychopharmacology 97: 471–475

    PubMed  CAS  Google Scholar 

  • Cohen BM, Baldessarini RJ (1985) Tolerance to therapeutic effects of antidepressants. Am J Psychiatry 142: 489–490

    PubMed  CAS  Google Scholar 

  • Dilsaver SC (1989) Antidepressant withdrawal syndromes: phenomenology and pathophysiology. Acta Psychiatr Scand 79: 113–117

    PubMed  CAS  Google Scholar 

  • Dilsaver SC, Greden JF (1984) Antidepressant withdrawal phenomena. Biol Psychiatry 19: 237–256

    PubMed  CAS  Google Scholar 

  • Dobson KS (1989) A meta-analysis of the efficacy of cognitive therapy for depression. J Consult Clin Psychol 57: 414–419

    PubMed  CAS  Google Scholar 

  • Eggers C (1992) Psychopharmakotherapie bei Kindern und Jugendlichen. In: Biederer P, Laux G, Poldinger W (HrSg) Neuro-Psychopharmaka, Bd 1. Allgemeine Grundlagen der Pharmakopsychiatrie. Springer, Wien New York, S 381–390

    Google Scholar 

  • Elia J, Katz IR, Simpson GM (1987) Teratogenicity of psychotherapeutic medications. Psychopharmacol Bull 23: 531–586

    Google Scholar 

  • Elkin J, Shea MT, Watkins JT, Imber SD et al. (1989) National Institute of Mental Health treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry 47: 971–982

    Google Scholar 

  • Emrich HM, Berger M, Riemann D, Zerssen Dv (1987) Serotonin reuptake inhibition vs. nor-epinephrine reuptake inhibition: a double-blind differential-therapeutic study with fluvoxamine and oxaprotiline in endogenous and neurotic depressives. Pharmacopsychiatry 20: 60–63

    PubMed  CAS  Google Scholar 

  • Fähndrich E (1983a) Clinical and biological parameters as predictors for antidepressant drug responses in depressed patients. Pharmacopsychiatry 16: 179–185

    Google Scholar 

  • Fähndrich E (1983b) Effect of sleep deprivation as a predictor of treatment response to antidepressant medication. Acta Psychiatr Scand 68: 341–344

    PubMed  Google Scholar 

  • Fähndrich E (1990) Biologische Prädiktoren für eine erfolgreiche antidepressive medikamentöse Behandlung. In: MOLLER H-J (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokyo, S 43–57

    Google Scholar 

  • Fairchild CJ, Rush J, Vasavada N, Giles DE, Khatami M (1986) Which depressions respond to placebo? Psychiatry Res 18: 217–226

    PubMed  CAS  Google Scholar 

  • Frank E, Kupfer DJ, Perel JM et al. (1990) Three-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47: 1093–1099

    PubMed  CAS  Google Scholar 

  • Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rustl AJ, Weissman MM (1991) Conceptualization and rationale for consensus definitions in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851–855

    Google Scholar 

  • Friedel RO (1983) Clinical predictors of treatment response: an update. In: Davis JM, Maas JW (eds) The affective disorders. American Psychiatric Press, Washington, pp 379–384

    Google Scholar 

  • Fritze J, Lanczik M, Boning J (1992) Adrenergcholinerge Gleichgewichtshypothese der Depression: Therapie mit Biperiden adjuvant zu Mianserin und Viloxazin. In: Gaebel W, Laux G (Hrsg) Biologische Psychiatrie. Synopsis 1990/91. Springer, Berlin Heidelberg New York Tokyo, S 327–331

    Google Scholar 

  • Georgotas A, Mccue RE, Hapworth W et al. (1986) Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychiatry 21: 1155–1166

    PubMed  CAS  Google Scholar 

  • Georgotas A,Mccue RE,Cooper TB (1989) A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 46: 783–786

    Google Scholar 

  • Gerner RH (1985) Present status of drug therapy of depression in late life. J Affect Disord [Suppl 1]: S 23–31

    Google Scholar 

  • Gerson SC, Plotkin DA, Jarvik LF (1988) Antidepressant drug studies, 1964 to 1986: empirical evidence for aging patients. J Clin Psychopharmacol 8: 311–322

    PubMed  CAS  Google Scholar 

  • Hale AS, Sandler M, Hannah P, Bridges PK (1989) Tyramine conjugation test for prediction of treatment response in depressed patients. Lancet i: 234–236

    Google Scholar 

  • Harkness L, Giller EL, Bialos D, Waldo MC (1982) Chronic depression: response to amitriptyline after discontinuation. Biol Psychiatry 17: 913917

    Google Scholar 

  • Helmchen H (1990) Gestuftes Vorgehen bei Resistenz gegen Antidepressiva-Therapie. In: Moller HJ (Hrsg) Therapieresistenz unter Antidepressiva-Behandlung. Springer, Berlin Heidelberg New York Tokyo, S 237–250

    Google Scholar 

  • Jarrett RB, Eaves GG, Grannemann BD, Rush AJ (1991) Clinical, cognitive, and demographic predictors of response to cognitive therapy for depression: a preliminary report. Psychiatry Res 37: 245–260

    PubMed  CAS  Google Scholar 

  • Jungkunz G (1989) Strategien und Hintergründe der medikamentösen Depressionsbehandlung. Stellung des Amitriptylinoxids in der Reihe der Antidepressiva. Vieweg, Braunschweig

    Google Scholar 

  • Katz MM, Koslow SH, Maas JW et al. (1987) The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med 17: 297–309

    PubMed  CAS  Google Scholar 

  • Khan A, Brown WA (1991) Who should receive antidepressants: suggestions from placebo treatment. Psychopharmacol Bull 27: 271–274

    PubMed  CAS  Google Scholar 

  • Khan A, Dager SR, Cohen S, Avery DH, Scherzo BA, DUNNER DL (1991) Chronicity of depressive episode in relation to antidepressant-placebo response. Neuropsychopharmacology 4: 125–130

    PubMed  CAS  Google Scholar 

  • Kielholz P, Adams C (Hrsg) (1984) Tropfinfusionen in der Depressionsbehandlung. Thieme, Stuttgart New York

    Google Scholar 

  • Klein HE, Rother E, Staedt J (1992) Kombinierte Psychopharmakotherapie einschließlich Behandlung chronischer Schmerzsyndrome. In: Riederer P, Laux G, Pöldinger W (Hrsg) Neuro-Psychopharmaka, Bd 1. Allgemeine Grundlagen der Pharmakopsychiatrie. Springer, Wien New York, S 425–458

    Google Scholar 

  • Klerman GL (1990) Treatment of recurrent unipolar major depressive disorder. Arch Gen Psychiatry 47: 1158–1162

    PubMed  CAS  Google Scholar 

  • Kupfer DJ, Frank E, Perel JM (1989) The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatry 46: 771775

    Google Scholar 

  • Kupfer DJ, Frank E, Mceachran AB, Grochocinski VJ (1990) Delta sleep ratio. A biological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 47: 1100–1105

    Google Scholar 

  • Lancaster SG, Gonzalez JP (1989) Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 38: 123–147

    Google Scholar 

  • Langer G, Aschauer H, Koinig G, Resch F, Schönbeck G (1983) The TSH-response to TRH: a possible predictor of outcome to antidepressant and neuroleptic treatment. Prog Neuropsychopharmacol Biol Psychiatry 7: 335–342

    PubMed  CAS  Google Scholar 

  • Lapierre YD (1989) A review of trimipramine: 30 years of clinical use. Drugs 38 [Suppll: 17–24

    Google Scholar 

  • Laux G (1983) Drip infusion therapy with clomipramine and maprotiline or the combination of both preparations. Vortrag VII. Weltkongreß für Psychiatrie (Abstract No F 643 )

    Google Scholar 

  • Laux G, König W (1992) Infusionstherapie bei Depressionen, 3. Aufl. Hippokrates, Stuttgart

    Google Scholar 

  • Laux G, Riederer P (Hrsg) (1992) Plasmaspiegelbestimmung von Psychopharmaka. Therapeutisches Drug-Monitoring. Versuch einer ersten Standortbestimmung. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Laux G, König W, Pfaff G, Becker U, Bauerle R (1988) Antidepressant combination therapy of endogenous depressions with benzodiazepines or neuroleptics — a study comparing adjuvant treatment with oxazolam versus chlorprothixene. Pharmacopsychiatry 21: 87–92

    PubMed  CAS  Google Scholar 

  • Linden M (1987) Phase-IV-Forschung. Antidepressiva in der Nervenarztpraxis. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Linden M (1991) Antidepressiva-Langzeitmedikation. In: Hippius H, Ortner M, Wither E (Hrsg) Psychiatrische Erkrankungen in der ärztlichen Praxis. Springer, Berlin Heidelberg New York Tokyo, S 1–17

    Google Scholar 

  • Loudon JB (1987) Prescribing in pregnancy: psy- chotropic drugs. Br Med J 294: 167–169

    CAS  Google Scholar 

  • Maas JW, Koslow S, Katz M et al. (1984) Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. Am J Psychiatry 141: 1159–1171

    PubMed  CAS  Google Scholar 

  • Martinsen EW (1990) Benefits of exercise for the treatment of depression. Sports Med 9: 380389

    Google Scholar 

  • Mcevoy JP, Mccue M, Spring B, Mohs RC, Lavori PW, Farr RM (1987) Effects of amantadine and trihexyphenidyl on memory in elderly normal volunteers. Am J Psychiatry 44: 573–577

    Google Scholar 

  • Möller HJ, Fischer G, V Zerssen D (1987) Prediction of therapeutic response in acute treatment with antidepressants. Eur Arch Psychiatr Neurol Sci 236: 349–357

    Google Scholar 

  • Montgomery S, Rouillon F (1992) (eds) Longterm treatment of depression. Wiley, Chichester New York

    Google Scholar 

  • Morris JB, Beck AT (1974) The efficacy of antidepressant drugs. Arch Gen Psychiatry 30: 667–674

    PubMed  CAS  Google Scholar 

  • Nagayama H, Nagano K, Ikezaki A, Tashiro T (1991) Prediction of efficacy of antidepressant by 1-week test therapy in depression. J Affect Disord 23: 213–216

    PubMed  CAS  Google Scholar 

  • Nelson JC(1991) Current status of tricyclic antidepressants in psychiatry: their pharmacology and clinical applications. J Clin Psychiatry 52: 193–200

    PubMed  CAS  Google Scholar 

  • Nelson JC, Bowers MB (1987) Delusional unipolar depression. Description and drug response. Arch Gen Psychiatry 35: 1321–1328

    Google Scholar 

  • Nimh/NIH Consensus Development Conference Statement (1985) Mood disorders: pharmacologic prevention of recurrences. Am J Psychiatry 142: 469–476

    Google Scholar 

  • Perry S (1990) Combining antidepressants and psychotherapy: rationale and strategies. J Clin Psychiatry 51 [Suppl: 16–20

    Google Scholar 

  • Peselow ED, Dunner DL, Fieve RR, Difiglia C (1991) The prophylactic efficacy of tricyclic antidepressants–a five year follow-up. Prog Neuropsychopharmacol Biol Psychiatry 15: 71–82

    PubMed  CAS  Google Scholar 

  • Peselow ED,Difiglia C, Fieve RR (1991b) Relationship of dose to antidepressant prophylactic efficacy. Acta Psychiatr Scand 84: 571–574

    Google Scholar 

  • Schmidt R (1985) Vorhersagbarkeit des Therapieansprechens depressiver Patienten auf Doxepin. In: PhilippM (Hrsg) Grundlagen and Erfolgsvorhersage der ambulanten Therapie mit Antidepressiva. Springer, Berlin Heidelberg New York Tokyo, S 29–45

    Google Scholar 

  • Priebe S (1987) Early subjective reactions predicting the outcome of hospital treatment in depressive patients. Acta Psychiatr Scand 76: 134–138

    PubMed  CAS  Google Scholar 

  • Prien RF, Kupfer DJ (1986) Continuation drug therapy for major depressive episodes: how long should it be maintained? Am J Psychiatry 143: 18–23

    PubMed  CAS  Google Scholar 

  • Prien RF, Carpenter LL, Kupfer DJ (1991) The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature. Arch Gen Psychiatry 48: 796–800

    Google Scholar 

  • Quitkin FM, Rabkin JG, ross D, MC Grath PJ (1984) Duration of antidepressant drug treatment. Arch Gen Psychiatry 41: 238–245

    PubMed  CAS  Google Scholar 

  • Quitkin FM, MC Grath PJ, Rabkin JG et al. (1991) Different types of placebo response in patients receiving antidepressants. Am J Psychiatry 148: 197–203

    PubMed  CAS  Google Scholar 

  • Rabkin JE, Stewart JW, MC Grath PJ, Markowitz JS, Harrison W, Quitkin FM (1987) Baseline characteristics of 10-day placebo washout responders in antidepressant trials. Psychiatry Res 21: 9–22

    PubMed  CAS  Google Scholar 

  • Rockwell E, Lam RW, Zisook S (1988) Antidepressant drug studies in the elderly. Psychiatry Clin North Am 1: 215–233

    Google Scholar 

  • Rush AJ, Roffwarg HP, Giles DE, Schlesser MA, Fairchild C, Tarell J (1983) Psychobiological predictors of antidepressant drug response. Pharmacopsychiatry 16: 192–194

    CAS  Google Scholar 

  • Rush AJ, Giles DE, Jarrett RB et al. (1989) Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry 26: 61–72

    PubMed  CAS  Google Scholar 

  • Sauer H, Lauter H (1987) Elektrokrampftherapie. Nervenarzt 58: 201–218

    CAS  Google Scholar 

  • Sauer H, Kick H, Minne HW, Schneider B (1986) Prediction of the amitriptyline response: psychopathology versus neuroendocrinology. Int Clin Psychopharmacol 1: 284–295

    PubMed  CAS  Google Scholar 

  • Schmidt LG, Schussler G, Linden M, Mulleroerlinghausen B (1988) Zur Häufigkeit und Therapierelevanz unerwünschter Wirkungen von Antidepressiva im Rahmen der ambulanten nervenärztlichen Behandlung. Fortschr Neurol Psychiat 56: 111–118

    PubMed  CAS  Google Scholar 

  • Sieberns S (1985) Internationale Erfahrungen mit Saroten® retard. In: Beckmann H, Sieberns S (Hrsg) Wie aktuell ist Amitriptylin für die Therapie der Depression? pmi Verlag, Frankfurt, S 183–190

    Google Scholar 

  • Sotsky SM, Glass DR, Shea MT, Pilkonis PA et al. (1991) Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH treatment of Depression Collaborative Research Program. Am J Psychiatry 148: 997–1008

    PubMed  CAS  Google Scholar 

  • Spiker DG, Weiss JC, Dealy RS, Griffin SJ, Hanin I et al. (1985) The pharmacological treatment of delusional depression. Am J Psychiatry 142: 4309–4436

    Google Scholar 

  • Stein MK, Rickels K, Weise CC (1980) Maintenance therapy with amitriptyline: a controlled trial. Am J Psychiatry 137: 370–371

    PubMed  CAS  Google Scholar 

  • Stravynski A, Greenberg D (1992) The psychological management of depression. Acta Psychiatr Scand 85: 407–414

    PubMed  CAS  Google Scholar 

  • Thase ME, Simons AD, Cahalane J, MC Geary J, Harden T (1991) Severity of depression and response to cognitive behavior therapy. Am J Psychiatry 148: 784–789

    PubMed  CAS  Google Scholar 

  • Thiels C (1992) Psychopharmaka in der Schwangerschaft und Stillzeit. In: Riederer P, Laux G, Poldinger W (Hrsg) Neuro-Psychopharmaka, Bd 1. Allgemeine Grundlagen der Pharmakopsychiatrie. Springer, Wien New York, S 353–380

    Google Scholar 

  • Tyrer P (1984) Clinical effects of abrupt withdrawal from tricyclic antidepressants and monoamine oxidase inhibitors after long-term treatment. J Affect Disord 6: 1–7

    PubMed  CAS  Google Scholar 

  • Wehr TA, Goodwin FK (1987) Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144: 1403–1411

    PubMed  CAS  Google Scholar 

  • Wirtz-Justice A, Pühringer W, Hole G (1979) Response to sleep deprivation as a predictor of therapeutic results with antidepressant drugs. Am J Psychiatry 136: 1222–1223

    Google Scholar 

  • Woggon B (1983) Prognose der Psychopharmakatherapie. Klinische Untersuchungen zur Voraussagbarkeit des Kurzzeittherapieerfolges von Neuroleptika und Antidepressiva. Enke, Stuttgart

    Google Scholar 

  • Woggon B (1987) Psychopharmakotherapie affektiver Psychosen. In: Kisker KP, Lauter H, Meyer J-E, Müller C, Strömgren E (Hrsg )Psychiatrie der Gegenwart 5. Affektive Psychosen. Springer, Berlin Heidelberg New York Tokyo, S 273-325

    Google Scholar 

  • Woggon B (1992) Prädiktoren für das Ansprechen auf Psychopharmaka. In: Riederer P, LAUX G, POLDINGER W (Hrsg) Neuro-Psycho-pharmaka, Bd 1. Allgemeine Grundlagen der Pharmakopsychiatrie. Springer, Wien New York, S 475–484

    Google Scholar 

  • Wolfersdorf M, Wohlt R, Hole G (Hrsg) (1985) Depressions-Stationen. Roderer, Regensburg

    Google Scholar 

Download references

Authors
  1. G. Laux
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. U. Breyer-Pfaff
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Delini-Stula
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Riederer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. König
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Fritze
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. O. Dietmaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Hebenstreit
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Neurochemie, Psychiatrische Universitätsklinik, Füchsleinstraße 15, D-97080, Würzburg, Bundesrepublik Deutschland

    Peter Riederer

  2. Psychiatrische Universitätsklinik, Sigmund-Freud-Straße 25, D-53105, Bonn, Bundesrepublik Deutschland

    Gerd Laux

  3. Psychiatrische Universitätsklinik, Wilhelm Klein-Straße 27, CH-4025, Basel, Schweiz

    Walter Pöldinger

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Wien

About this chapter

Cite this chapter

Laux, G. et al. (1993). Trizyklische Antidepressiva. In: Riederer, P., Laux, G., Pöldinger, W. (eds) Neuro-Psychopharmaka. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3317-0_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3317-0_2

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-3318-7

  • Online ISBN: 978-3-7091-3317-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation